Answers are grounded in this paper and cite their sources.
This study evaluated the in vitro α-glucosidase and dipeptidyl peptidase-IV (DPP-IV) inhibitory and antioxidant activities of Glehnia littoralis leaves and stems, which are traditionally consumed but less studied than the roots. The 70% ethanol extract was partitioned into three fractions (F1, F2, F3). Fraction 2 (F2) concentrated total phenolics (234.71 mg GAE/g) and flavonoids (155.61 mg QE/g) most effectively, showing strong DPPH radical scavenging activity (IC50 = 32.09 µg/mL). F2 also demonstrated dual-targeting inhibitory efficacy against α-glucosidase (IC50 = 314.41 µg/mL) and DPP-IV (IC50 = 209.67 µg/mL), comparable to acarbose in α-glucosidase inhibition (yeast enzyme assay), though much less potent than sitagliptin against DPP-IV. Exploratory non-targeted metabolomics highlighted rutin and quercetin 3-β-D-glucoside (Q3G) as discriminating markers (VIP ≥ 2.0); their contents in F2, estimated by Parallel Reaction Monitoring, were 188.97 mg/g and 43.44 mg/g, respectively. In a concentration-addition analysis, the summed dose fractions of rutin, Q3G, and chlorogenic acid at the IC50 of F2 were approximately 0.32 and 0.62 for α-glucosidase and DPP-IV, respectively, suggesting contributions from additional, untested constituents such as kaempferol-3-O-rutinoside. These findings indicate that Glehnia littoralis leaves and stems merit further investigation as potential functional food resources for blood glucose regulation, pending cell-based and in vivo validation.
No takes yet. Share an insight, caveat, or question.
Choi et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: